Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

NCT00539695 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
ALL
Acute Myelogenous Leukemia
AML
Chronic Myelogenous Leukemia
Myelodysplastic Syndrome
Myeloproliferative Disorder
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Non-malignant Diseases Requiring Allogeneic HSCT

Interventions

BIOLOGICAL: IL-2

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]